Lynch Syndrome

Chicago, IL—Tumors with high microsatellite instability (MSI-H) are predictive of Lynch syndrome. The recent approval of the first immunotherapies for use in patients with MSI-H or with mismatch repair-deficiency (dMMR) in solid tumors is now leading to routine testing for MSI-H or dMMR in patients with advanced solid tumors.

“Because of this relatively high prevalence, universal tumor screening of all colon and endometrial cancers is now recommended for markers of Lynch syndrome,” said Zsofia Kinga Stadler, MD.

Results 1 - 2 of 2